Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Bariatric Surgery Devices Market Size & Growth Forecast 2027–2036, By Segments (Device, End Use, Procedure), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 5272| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Bariatric Surgery Devices Market size was more than USD 2.91 billion in 2026 and is set to grow at a 5.13% CAGR between 2027 and 2036, surpassing USD 4.8 billion by 2036. The industry revenue for 2027 is calculated at USD 3.04 billion.

Base Year Value (2026)
USD 2.91 billion
CAGR (2027-2036)
5.13%
Forecast Year Value (2036)
USD 4.8 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
SNAPSHOT

Bariatric Surgery Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads due to established bariatric ecosystems, advanced hospital infrastructure, high surgical expertise, and consistent use of minimally invasive procedures supporting steady device demand.
  • Asia Pacific is expanding at a 6.22% CAGR, driven by improving hospital capabilities, rising obesity treatment adoption, and increasing access to laparoscopic and metabolic surgery procedures.

Segment Momentum

  • Minimally Invasive Surgical Devices held a 62.18% share in 2026 due to their established use in routine bariatric procedures, reliable performance, and compatibility with standard surgical workflows.
  • Bariatric Surgery Clinics are the fastest-growing end-use segment as providers increasingly favor specialized settings that streamline patient assessment, procedure planning, and follow-up within dedicated obesity-care pathways.

Market Expansion Drivers

  • Rising global obesity prevalence increasing demand for surgical weight management procedures.
  • Growing adoption of minimally invasive bariatric procedures driving advanced surgical device utilization.
  • Increasing healthcare investments in obesity treatment programs expanding bariatric surgery accessibility.

Leading Market Participants

  • Leading companies in the bariatric surgery devices market include Johnson & Johnson (United States), Medtronic plc (Ireland), Apollo Endosurgery Inc. (United States), Olympus Corporation (Japan), CONMED Corporation (United States), Intuitive Surgical, Inc. (United States), Boston Scientific Corporation (United States), Asensus Surgical, Inc. (United States), ReShape Lifesciences Inc. (United States).

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 2.91 billion
  • 2027 Estimated Market Size: USD 3.04 billion.
  • Projected Market Size: USD 4.8 billion by 2036
  • Growth Forecast: 5.13% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Minimally Invasive Surgical Devices (Device) | Hospitals & Ambulatory Surgery Centers (End Use) | Sleeve Gastrectomy (Procedure)
  • Emerging Opportunity Segment: Non-invasive Surgical Devices (Device) | Bariatric Surgery Clinics (End Use) | Non-invasive Bariatric Surgery (Procedure)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising global obesity prevalence increasing demand for surgical weight management procedures

The increasing prevalence of obesity is expanding the population requiring clinically supervised interventions for long-term weight management. The bariatric surgery devices market will benefit as more healthcare providers and patients consider surgical procedures when lifestyle-based approaches are insufficient for managing severe obesity and associated health risks. This growing clinical need is supporting demand for devices used in procedures such as gastric restriction and gastrointestinal rerouting, with hospitals requiring reliable equipment to perform increasingly specialized bariatric interventions.

Growing adoption of minimally invasive bariatric procedures driving advanced surgical device utilization

The shift toward minimally invasive approaches is encouraging the adoption of surgical technologies that can support smaller incisions, improved procedural control, and more efficient recovery pathways. Within the bariatric surgery devices market, this transition is increasing demand for laparoscopic instruments, stapling systems, energy devices, visualization technologies, and other specialized equipment designed for minimally invasive procedures. Surgeons are also seeking devices that provide greater precision and ergonomic control during complex bariatric operations, particularly as minimally invasive techniques become more established in clinical practice.

Increasing healthcare investments in obesity treatment programs expanding bariatric surgery accessibility

Greater healthcare investment in obesity management is supporting the development and expansion of treatment programs that incorporate surgical interventions alongside medical and lifestyle-based care. The bariatric surgery devices market is supported by this investment as hospitals and healthcare facilities allocate resources toward specialized bariatric services, surgical infrastructure, and trained clinical teams. Improved availability of dedicated obesity treatment pathways can also make bariatric procedures more accessible to eligible patients by integrating surgical weight management into broader healthcare delivery systems.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising global obesity prevalence increasing demand for surgical weight management procedures 2.20% High North America, Asia Pacific High Near Term
Growing adoption of minimally invasive bariatric procedures driving advanced surgical device utilization 1.90% High North America, Europe High Mid Term
Increasing healthcare investments in obesity treatment programs expanding bariatric surgery accessibility 1.50% Moderate Asia Pacific, Latin America Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

North America held the largest share of the bariatric surgery devices market in 2026, supported by advanced surgical infrastructure, established bariatric care services, and strong adoption of minimally invasive medical technologies. The region's healthcare system has substantial capabilities for obesity management and complex surgical procedures, creating sustained demand for specialized devices used in bariatric interventions. Growing clinical emphasis on effective weight-management approaches, improvements in surgical techniques, and continued investment in advanced hospital equipment are further contributing to the region's leading position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific represents the fastest-growing regional market, driven by changing lifestyles, increasing awareness of obesity-related health risks, and improving access to specialized surgical care. Healthcare infrastructure is expanding across the region, while hospitals are increasingly incorporating advanced surgical technologies to address evolving patient needs. Greater awareness of bariatric procedures, rising demand for minimally invasive interventions, and efforts to strengthen access to modern healthcare services are supporting broader adoption of bariatric surgery devices and creating significant opportunities for market development.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Minimally Invasive Excellence

Germany prioritizes bariatric surgery devices that support precision, safety, and minimally invasive surgical approaches. German hospitals increasingly integrate advanced laparoscopic technologies while emphasizing procedural consistency and high clinical standards for obesity treatment.

France 🇫🇷

Hospital Innovation Focus

France strengthens its bariatric surgery devices market through hospital investment in advanced laparoscopic equipment and standardized surgical practices. French healthcare providers emphasize procedural quality, multidisciplinary obesity care, and technology that supports efficient surgical intervention.

Italy 🇮🇹

Expanding Surgical Access

Italy continues broadening access to bariatric surgery by strengthening specialized surgical centers and adopting modern minimally invasive devices. Italian healthcare providers focus on practical technology upgrades that improve workflow efficiency while supporting comprehensive obesity management programs.

Japan 🇯🇵

Precision Surgical Care

Japan focuses on bariatric surgery devices that enhance procedural precision and support carefully selected patient populations. Japanese healthcare providers emphasize reliable surgical performance, advanced imaging integration, and clinical outcomes through specialized obesity treatment programs.

South Korea 🇰🇷

Technology-Driven Procedures

South Korea adopts bariatric surgery devices alongside expanding minimally invasive surgical capabilities and modern hospital infrastructure. South Korean providers prioritize advanced surgical platforms and efficient operating workflows to improve obesity treatment and patient recovery.

United States 🇺🇸

Advanced Procedure Adoption

The U.S. bariatric surgery devices market benefits from broad adoption of minimally invasive surgical techniques and ongoing innovation in surgical technologies. Healthcare providers in the U.S. continue investing in advanced stapling, energy, and visualization devices that improve procedural efficiency.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Bariatric Surgery Devices Market Share (%), by Device, 2026

Minimally Invasive Surgical Devices
Non-invasive Surgical Devices

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Device Segment Analysis: Minimally Invasive Surgical Devices (Largest Segment) vs Non-invasive Surgical Devices (Fastest-Growing Segment)

Minimally invasive surgical devices dominated the bariatric surgery devices market, accounting for a 62.18% share in 2026, driven by their ability to support bariatric procedures through smaller access points and reduced tissue disruption compared with conventional surgical approaches. These devices are widely valued for supporting procedures that can reduce postoperative discomfort, facilitate recovery, and improve the overall surgical experience when clinically appropriate. Increasing adoption of minimally invasive techniques across bariatric care is also supported by improvements in visualization, instrumentation, and procedural precision. As healthcare providers continue to emphasize patient-centered surgical approaches and efficient recovery pathways, demand for specialized minimally invasive bariatric devices remains strong.

Non-invasive surgical devices are experiencing the fastest growth as bariatric care increasingly explores approaches that can minimize procedural burden and expand treatment options for patients who may not be suitable for conventional surgery. Technological progress is enabling the development of solutions designed to address obesity management with reduced reliance on invasive intervention, supporting interest among healthcare providers and patients. Growing emphasis on personalized weight-management strategies and the pursuit of procedures with reduced recovery requirements are further creating opportunities for non-invasive approaches. As innovation continues to broaden the range of bariatric treatment options, non-invasive surgical technologies are gaining greater relevance within the evolving device landscape.

End Use Segment Analysis: Hospitals & Ambulatory Surgery Centers (Largest Segment) vs Bariatric Surgery Clinics (Fastest-Growing Segment)

Hospitals and ambulatory surgery centers accounted for the largest share of the bariatric surgery devices market at 62.27% in 2026, reflecting their established role in delivering surgical weight-management procedures and providing access to specialized clinical infrastructure. These facilities offer multidisciplinary teams, operating environments, anesthesia services, postoperative monitoring, and access to complementary diagnostic and therapeutic resources required for bariatric interventions. Their ability to manage patients across different stages of treatment also supports the adoption of specialized surgical devices. Continued emphasis on structured obesity care and the availability of comprehensive surgical services are reinforcing the importance of hospitals and ambulatory surgery centers as primary end-use settings.

Bariatric surgery clinics are expanding at the fastest pace as specialized centers increasingly focus on dedicated obesity treatment pathways and patient-centered surgical care. These clinics can provide focused expertise in bariatric procedures, preoperative assessment, postoperative follow-up, nutritional support, and long-term weight-management services. Their specialized operating models can also help create more streamlined patient experiences by concentrating bariatric expertise within a dedicated care environment. Growing demand for specialized obesity services and greater interest in focused treatment settings are supporting the expansion of bariatric surgery clinics and increasing their importance within the end-use landscape.

Segment Sub-Segment Largest Segment Fastest Growing
Device Minimally Invasive Surgical Devices, Non-invasive Surgical Devices Minimally Invasive Surgical Devices Non-invasive Surgical Devices
End Use Bariatric Surgery Clinics, Hospitals & Ambulatory Surgery Centers, Others Hospitals & Ambulatory Surgery Centers Bariatric Surgery Clinics
Procedure Sleeve Gastrectomy, Gastric Bypass, Revision Bariatric Surgery, Non-invasive Bariatric Surgery, Adjustable Gastric Banding, Mini-Gastric Bypass, Others Sleeve Gastrectomy Non-invasive Bariatric Surgery
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the bariatric surgery devices market:

1. Johnson & Johnson (United States)

2. Medtronic plc (Ireland)

3. Apollo Endosurgery Inc. (United States)

4. Olympus Corporation (Japan)

5. CONMED Corporation (United States)

6. Intuitive Surgical Inc. (United States)

7. Boston Scientific Corporation (United States)

8. Asensus Surgical Inc. (United States)

9. ReShape Lifesciences Inc. (United States)

The bariatric surgery devices market is evolving through increasing focus on minimally invasive weight-management procedures and advanced surgical technologies. Market participants are enhancing device precision, procedural safety, and post-surgical recovery outcomes through continuous innovation in stapling systems, robotic assistance, and visualization tools. Rising obesity prevalence and demand for effective long-term treatment solutions are also supporting market growth.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Johnson & Johnson (United States)
Medtronic plc (Ireland)
Apollo Endosurgery Inc. (United States)
Olympus Corporation (Japan)
CONMED Corporation (United States)
Intuitive Surgical Inc. (United States)
Boston Scientific Corporation (United States)
Asensus Surgical Inc. (United States)
ReShape Lifesciences Inc. (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Olympus May-23 Olympus launched the POWERSEAL Sealer/Divider in the EMEA region. This bipolar surgical instrument provides state-of-the-art dissection and vessel sealing capabilities for open and laparoscopic procedures. The launch enhances the company's operational offerings for bariatric surgeons, focusing on efficiency and consistency in complex weight-loss surgeries.
Boston Scientific Nov-22 Boston Scientific completed the acquisition of Apollo Endosurgery, Inc., a specialist in endoluminal surgery devices. The acquisition expanded Boston Scientific's portfolio to include advanced tools for gastrointestinal defect closure and endoscopic weight loss management, enhancing its strategic presence in the minimally invasive bariatric and metabolic surgery segments.
Spatz Medical Oct-21 Spatz Medical received U.S. FDA approval for the Spatz3 Adjustable Gastric Balloon, the first adjustable device of its kind to aid in weight loss for adult patients. This regulatory clearance enabled the company to introduce a differentiated, reversible treatment option into the U.S. bariatric market, offering a more flexible alternative to traditional permanent surgical procedures.
ReShape Lifesciences Inc. Jun-21 ReShape Lifesciences completed a merger with Obalon Therapeutics to create an expanded entity focused on weight loss solutions. The consolidation combined complementary portfolios of FDA-approved intragastric balloons and virtual care services, allowing the firm to scale its commercial infrastructure and reach a broader patient demographic within the obesity management market.
Johnson & Johnson Mar-21 Johnson & Johnson launched the ECHELON+ Stapler with GST Reloads, a powered surgical stapler designed to improve outcomes in bariatric and general surgery. By utilizing advanced technology for more uniform tissue compression and improved staple formation, the device aims to reduce perioperative complications, reinforcing the company's innovation leadership in surgical instrumentation.
Intuitive Surgical, Inc. Mar-20 Intuitive Surgical received regulatory clearance in Japan to market its SynchroSeal instrument. The device, designed for use with robotic surgical systems, enables advanced vessel sealing and tissue transection, supporting the company's strategy to provide specialized, high-precision tools that enhance the efficacy of robotic-assisted bariatric and general surgical procedures.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Bariatric Surgery Devices Market — Custom Segments

Segment Sub-Segment
Reusability Single-Use Devices, Reusable Devices
Patient Obesity Class Class I Obesity, Class II Obesity, Class III Obesity
Device Usage Stage Primary Surgery Devices, Revision Surgery Devices, Post-Surgical Management Devices

Bariatric Surgery Devices Market — Custom

Custom Chapter Custom Details
Bariatric Center of Excellence Adoption Benchmarking
  • Center-of-Excellence Models and Adoption Patterns
  • Institutional Capability and Service-Line Development
  • Clinical Infrastructure and Device Utilization Practices
  • Accreditation, Quality, and Patient-Outcome Considerations
  • Benchmarking of Leading Bariatric Care Models
Procedure Economics and Hospital Profitability Assessment
  • Bariatric Procedure Cost and Resource Utilization Drivers
  • Operating Room Efficiency and Length-of-Stay Economics
  • Device-Related Cost Considerations and Procurement Priorities
  • Reimbursement Environment and Revenue Implications
  • Hospital Profitability Levers and Economic Optimization Opportunities
Patient Access and Referral Pathway Analysis
  • Bariatric Patient Identification and Referral Pathways
  • Referral Sources and Provider Engagement Models
  • Access Barriers Across Diagnosis, Evaluation, and Treatment
  • Patient Conversion and Care-Continuity Considerations
  • Opportunities to Strengthen Bariatric Referral Networks

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current size of the bariatric surgery devices market?

As of 2027 the market size of bariatric surgery devices is valued at USD 3.04 billion.

What is the projected value of the bariatric surgery devices industry by 2036?

Bariatric Surgery Devices Market size was more than USD 2.91 billion in 2026 and is set to grow at a 5.13% CAGR between 2027 and 2036, surpassing USD 4.8 billion by 2036.

Why are minimally invasive procedures accelerating demand for advanced bariatric surgery devices?

Hospitals increasingly favor minimally invasive techniques because they improve procedural efficiency and recovery outcomes, driving greater adoption of specialized stapling, visualization, access, and vessel-sealing technologies across bariatric surgery programs.

How are healthcare investments expanding commercial opportunities in the bariatric surgery devices market?

Increased funding for obesity treatment expands surgical capacity, specialist training, and patient referral pathways, leading more healthcare facilities to procure bariatric surgical devices and integrate procedures into routine clinical practice.

Why do minimally invasive surgical devices dominate the bariatric surgery devices market?

Minimally Invasive Surgical Devices held a 62.18% share in 2026 due to their established use in routine bariatric procedures, reliable performance, and compatibility with standard surgical workflows.

What is fueling growth in bariatric surgery clinics as an end-use segment?

Bariatric Surgery Clinics are the fastest-growing end-use segment as providers increasingly favor specialized settings that streamline patient assessment, procedure planning, and follow-up within dedicated obesity-care pathways.

Why does North America lead the bariatric surgery devices market?

North America leads due to established bariatric ecosystems, advanced hospital infrastructure, high surgical expertise, and consistent use of minimally invasive procedures supporting steady device demand.

What is driving bariatric device adoption in Asia Pacific?

Asia Pacific is expanding at a 6.22% CAGR, driven by improving hospital capabilities, rising obesity treatment adoption, and increasing access to laparoscopic and metabolic surgery procedures.

Who are the leading players in the bariatric surgery devices landscape?

Leading companies in the bariatric surgery devices market include Johnson & Johnson (United States), Medtronic plc (Ireland), Apollo Endosurgery Inc. (United States), Olympus Corporation (Japan), CONMED Corporation (United States), Intuitive Surgical, Inc. (United States), Boston Scientific Corporation (United States), Asensus Surgical, Inc. (United States), ReShape Lifesciences Inc. (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →